To analyze the contribution of progranulin (PGRN) to the etiopathogenesis of amyotrophic lateral sclerosis (ALS), we performed a PGRN gene screening in 146 Italian patients (12 familial cases) and evaluated the association of two common variants with risk of developing ALS in 239 sporadic cases (SALS). Progranulin mRNA and protein levels were measured in peripheral blood mononuclear cells and serum of a subset of these patients and controls. PGRN sequence analysis revealed a heterozygous change (p.S120Y), previously observed in an independent sporadic ALS-FTD patient. Haplotype analysis showed a conserved PGRN region among these two subjects consistent with possible common ancestor allele. Two non-coding polymorphisms were not associated to increased risk to develop ALS; mRNA and serum levels were not significantly different between cases and controls. Overall, our data argue against the hypothesis of progranulin as a major risk factor for motor neuron dysfunction, at least in Italian population. The p.S120Y variant may characterize rare patients with SALS, although its pathogenetic mechanism remains to be elucidated.

No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort / S. Corti, D. Santoro, I. Ghione, C. Fenoglio, S. Ghezzi, M. Ranieri, D. Galimberti, M. Mancuso, G. Siciliano, C. Briani, L. Murri, E. Scarpini, J. Schymick, B. Traynor, N. Bresolin, G. Comi. - In: NEUROBIOLOGY OF AGING. - ISSN 0197-4580. - 32:6(2011 Jun), pp. 1157-1158. [10.1016/j.neurobiolaging.2009.06.006]

No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort

S. Corti
Primo
;
D. Santoro
Secondo
;
I. Ghione;C. Fenoglio;M. Ranieri;D. Galimberti;E. Scarpini;N. Bresolin
Penultimo
;
G. Comi
Ultimo
2011

Abstract

To analyze the contribution of progranulin (PGRN) to the etiopathogenesis of amyotrophic lateral sclerosis (ALS), we performed a PGRN gene screening in 146 Italian patients (12 familial cases) and evaluated the association of two common variants with risk of developing ALS in 239 sporadic cases (SALS). Progranulin mRNA and protein levels were measured in peripheral blood mononuclear cells and serum of a subset of these patients and controls. PGRN sequence analysis revealed a heterozygous change (p.S120Y), previously observed in an independent sporadic ALS-FTD patient. Haplotype analysis showed a conserved PGRN region among these two subjects consistent with possible common ancestor allele. Two non-coding polymorphisms were not associated to increased risk to develop ALS; mRNA and serum levels were not significantly different between cases and controls. Overall, our data argue against the hypothesis of progranulin as a major risk factor for motor neuron dysfunction, at least in Italian population. The p.S120Y variant may characterize rare patients with SALS, although its pathogenetic mechanism remains to be elucidated.
Amyotrophic lateral sclerosis; Progranulin; Genetic risk factor; Susceptibility
Settore MED/26 - Neurologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort. .pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 102.1 kB
Formato Adobe PDF
102.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/250752
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
social impact